About this trial
The purposes of this study are to collect and store samples including blood, normal and tumor tissue from patients with colorectal cancer or gastric cancer, to collect and store samples including blood and/or normal gastrointestinal tissue (if available) from patients with non-malignant disease (including, but not limited to, inflammatory bowel disease (IBD), gastric ulcer, hemorrhoids or hernia), and to create a database for the collected samples and allow access to relevant clinical information for current and future protocols.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Any patient diagnosed with colorectal cancer, gastric cancer, non-malignant disease that requires undergoing surgery.
Must be willing and able to provide informed consent.
Disqualifiers
Subjects whose comorbidities would preclude diagnostic or therapeutic intervention.
Trial population
Participants who are planning to undergo surgery.
Trial design
Case-only
Prospective
Treatments tested in this trial
No intervention will be given to patients.
Other interventionSamples are collected at the time of a scheduled surgery that is part of normal treatment. This study will not have any impact on the care or treatment the patient receives.
Treatment groups
Trial outcomes
Primary outcomes
Confirmation of diagnosis by pathologist
Once tissue is collected, those samples that have a confirmed diagnosis of disease by the pathologist will be used.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.